logo.jpg
Vallon Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference
March 03, 2021 08:35 ET | Vallon Pharmaceuticals Inc.
PHILADELPHIA, PA, March 03, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
Achilles-Therapeutics-Logo-RGB-Small.png
Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States
March 01, 2021 18:26 ET | Achilles Therapeutics
Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States London, UK 1 March 2021 – Achilles Therapeutics plc (“Achilles” or the...
logo color s and clearside.jpg
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021
February 23, 2021 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
TreviLogo.png
Trevi Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference
February 18, 2021 16:05 ET | Trevi Therapeutics
NEW HAVEN, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast Featuring Mark Palumbo, Founder & CEO of CannAssist International Corp.
February 17, 2021 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Syneos Health_rgb_r.jpg
Syneos Health Identifies Important Drivers of Change Expected to Disrupt Healthcare
February 11, 2021 08:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, is pulsing a series of 2021 Health Trends –...
US Capital Global Securities Launches $7MM Preferred Stock Offering for Dianomi Therapeutics, Inc.
February 09, 2021 17:55 ET | US Capital Global
San Francisco, California, Feb. 09, 2021 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, is offering to eligible investors an investment opportunity of up to...
TreviLogo.png
Trevi Therapeutics Appoints William Forbes, Pharm.D. as Chief Development Officer
February 01, 2021 07:30 ET | Trevi Therapeutics
Industry Veteran to Lead the Clinical Development of Haduvio™ in Multiple Indications NEW HAVEN, Conn., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage...
Ligature Therapeutics Launches, Raises USD $6M in Seed Financing
January 04, 2021 19:00 ET | Ligature Therapeutics Pte Ltd
SINGAPORE, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” therapeutics, has announced the close of USD $6...
Syneos Health_rgb_r.jpg
Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 16:15 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...